Followers | 83 |
Posts | 36200 |
Boards Moderated | 0 |
Alias Born | 03/09/2010 |
Saturday, December 14, 2019 4:28:57 PM
Print Share
Generic Adderall XR Availability
See also: Generic Adderall
Adderall XR is a brand name of amphetamine/dextroamphetamine, approved by the FDA in the following formulation(s):
ADDERALL XR 10 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate - capsule, extended release;oral)
Manufacturer: SHIRE
Approval date: October 11, 2001
Strength(s): 2.5MG;2.5MG;2.5MG;2.5MG [RLD] [AB]
Manufacturer: SHIRE
Approval date: May 22, 2002
Strength(s): 3.75MG;3.75MG;3.75MG;3.75MG [RLD] [AB]
Manufacturer: SHIRE
Approval date: October 11, 2001
Strength(s): 5MG;5MG;5MG;5MG [RLD] [AB]
Manufacturer: SHIRE
Approval date: May 22, 2002
Strength(s): 6.25MG;6.25MG;6.25MG;6.25MG [RLD] [AB]
Manufacturer: SHIRE
Approval date: October 11, 2001
Strength(s): 7.5MG;7.5MG;7.5MG;7.5MG [RLD] [AB]
Manufacturer: SHIRE
Approval date: May 22, 2002
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [RLD] [AB]
Has a generic version of Adderall XR been approved?
DEXTROAMP SACCHARATE, AMP ASPARTATE, DETROAMP SULFATE AND AMP SULFATE (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate capsule, extended release;oral)
Manufacturer: PAR PHARM INC
Approval date: May 31, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate capsule, extended release;oral)
Manufacturer: ACTAVIS ELIZABETH
Approval date: June 22, 2012
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: AMERIGEN PHARMS LTD
Approval date: January 22, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: IMPAX LABS
Approval date: February 16, 2016
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: NESHER PHARMS
Approval date: July 17, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: RHODES PHARMS
Approval date: May 17, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: SPECGX LLC
Approval date: April 22, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: SUN PHARM INDUSTRIES
Approval date: May 17, 2019
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
Manufacturer: TEVA
Approval date: April 29, 2013
Strength(s): 1.25MG;1.25MG;1.25MG;1.25MG [AB], 2.5MG;2.5MG;2.5MG;2.5MG [AB], 3.75MG;3.75MG;3.75MG;3.75MG [AB], 5MG;5MG;5MG;5MG [AB], 6.25MG;6.25MG;6.25MG;6.25MG [AB], 7.5MG;7.5MG;7.5MG;7.5MG [AB]
THEY HATE ME CAUSE THEY AINT ME
ESPECIALLY ABOUT THE ISRADIPINE SCAM
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM